| scholarly article | Q13442814 |
| P50 | author | Zoltan Szallasi | Q30347479 |
| Marcin Krzystanek | Q41114537 | ||
| Valéria Jósa | Q90191915 | ||
| László Harsányi | Q112502833 | ||
| P2093 | author name string | Zsolt Baranyai | |
| Ferenc Salamon | |||
| Viktória Juhász | |||
| Balázs Tihanyi | |||
| Tamás Vass | |||
| Kamilla Szilágyi | |||
| Tamás Lang | |||
| P2860 | cites work | Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability | Q22242922 |
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Deadly allies: the fatal interplay between platelets and metastasizing cancer cells | Q24623647 | ||
| Tumor-platelet interaction in solid tumors | Q26853099 | ||
| Cancer-related inflammation | Q27860907 | ||
| Inflammation and cancer: back to Virchow? | Q28036756 | ||
| Thrombocytosis | Q28167883 | ||
| Apoptosis in the pathogenesis and treatment of disease | Q28235731 | ||
| Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator | Q31934730 | ||
| Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib study. | Q33488193 | ||
| Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count | Q33595350 | ||
| Outcome following surgery for colorectal cancer: analysis by hospital after adjustment for case-mix and deprivation | Q34116899 | ||
| The importance of IL-6 protein expression in primary human renal cell carcinoma: an immunohistochemical study | Q35396328 | ||
| Paraneoplastic thrombocytosis in ovarian cancer. | Q35812402 | ||
| Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas | Q36081099 | ||
| The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder. | Q36611805 | ||
| An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. | Q36614306 | ||
| Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. | Q36615780 | ||
| Development and validation of a predictive model for chemotherapy-associated thrombosis | Q36657982 | ||
| Platelets: guardians of tumor vasculature | Q37543821 | ||
| Contribution of platelets to tumour metastasis. | Q37831798 | ||
| The dynamics of colorectal cancer management in 17 countries | Q39919136 | ||
| Lung cancer producing interleukin-6. | Q40671298 | ||
| Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study | Q40696313 | ||
| Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases | Q40738064 | ||
| Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis | Q40772902 | ||
| Prognostic significance of thrombocytosis in patients with primary lung cancer | Q40928757 | ||
| Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase. | Q41644915 | ||
| Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin | Q42288194 | ||
| IL-3 does not contribute to platelet production in c-Mpl-deficient mice | Q42494001 | ||
| Culture and properties of cells derived from Kaposi sarcoma | Q44563107 | ||
| Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? | Q45753071 | ||
| Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial | Q46472385 | ||
| Megakaryocytopoiesis in experimental iron deficiency anemia | Q47895814 | ||
| Platelet production in experimental iron deficiency anemia. | Q47912774 | ||
| High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). | Q51605266 | ||
| Impact of pretreatment hematologic profile on survival of colorectal cancer patients. | Q51777037 | ||
| Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production. | Q54003147 | ||
| The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer. | Q54524001 | ||
| Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. | Q55039060 | ||
| Poor prognosis associated with thrombocytosis in patients with cervical cancer. | Q55040896 | ||
| Impact of pretreatment thrombocytosis on survival in primary breast cancer | Q59616859 | ||
| C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality | Q59649682 | ||
| Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer | Q72313726 | ||
| Serum interleukin 6 as a prognostic factor in patients with prostate cancer | Q74067164 | ||
| Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis | Q74130262 | ||
| Lysis of tumor cells by natural killer cells in mice is impeded by platelets | Q74650896 | ||
| Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer | Q79634887 | ||
| Inflammation and necrosis promote tumour growth | Q80402773 | ||
| Preoperative serum C-reactive protein level in non-small cell lung cancer | Q80789268 | ||
| Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer | Q82298218 | ||
| Role of preoperative platelet level in clinical and pathological outcomes after surgery for renal cortical malignancies | Q82933988 | ||
| Platelet count and tumor progression in gastric cancer patients | Q84023917 | ||
| Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis | Q84146756 | ||
| P433 | issue | 4 | |
| P921 | main subject | liver metastasis | Q18967325 |
| colorectal cancer | Q188874 | ||
| P304 | page(s) | 991-997 | |
| P577 | publication date | 2015-03-13 | |
| P1433 | published in | Pathology Oncology Research | Q26842743 |
| P1476 | title | Thrombocytosis of Liver Metastasis from Colorectal Cancer as Predictive Factor | |
| P478 | volume | 21 |
| Q48234813 | Cautious use of platelet as a relevant inducer of liver regeneration following partial hepatectomy in patients with metastatic hepatic carcinoma |
| Q58797887 | Evaluation of platelet indices as diagnostic biomarkers for colorectal cancer |
| Q55293992 | Poor prognostic role of the pretreatment platelet counts in colorectal cancer: A meta-analysis. |
| Q36189355 | Prognostic significance of pretreatment elevated platelet count in patients with colorectal cancer: a meta-analysis |
| Q41845316 | The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysis |
| Q36252250 | The pretreatment thrombocytosis may predict prognosis of patients with colorectal cancer: a systematic review and meta-analysis |
Search more.